Microbiological, n (%) | |
---|---|
Patients with isolated microorganism | 305 (58.9) |
Patients with at least one MDR organism | 88 (17.0) |
Patients with at least one ESBL organism | 50 (9.7) |
E. coli ESBL + | 43 (8.3) |
Methicillin-resistant S. aureus | 20 (3.9) |
Proteus spp MDR + | 5 (1) |
K. pneumoniae ESBL + | 7 (1.4) |
K. pneumomiae carbapenemase producer | 6 (1.2) |
P. aeruginosa MDR+ | 4 (0.8) |
Enterococcus spp MDR+ | 2 (0.4) |
Enterobacter spp MDR + | 2 (0.4) |
Stenotrophomonas maltophilia MDR+ | 1 (0.2) |
E. coli ESBL - | 77 (14.9) |
Methicillin-sensible S. aureus | 24 (4.6) |
S. pneumoniae | 24 (4.6) |
K. pneumoniae ESBL- | 17 (3.3) |
P. aeruginosa MDR- | 25 (4.8) |
Candida spp | 12 (2.3) |
Enterococcus spp MDR- | 10 (1.9) |
Proteus spp MDR-) | 9 (1.7) |
Enterobacter spp MDR- | 5 (1) |
N. meningitides | 3 (0.6) |
Bacteroides spp | 1 (0.2) |
Providencia spp | 2 (0.4) |
Stenotrophomonas maltophilia MDR- | 3 (0.6) |
C. difficile | 4 (0.8) |
Aspergillus spp | 2 (0.4) |
Acinetobacter baumanii | 1 (0.2) |
Salmonella group B | 2 (0.4) |
H. influenzae | 1 (0.2) |
Acinetobacter iwoffii | 1 (0.2) |
Propiniobacterium | 1 (0.2) |
Serratia spp | 2 (0.4) |
Polymicrobial infection | 29 (5.6) |